Gabapentin’s effect on human dorsal root ganglia: Donor-specific electrophysiological and transcriptomic profiles
Molecular Pain · 2025-08 · 21
DOI: 10.1177/17448069251361712 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Pain, online erschienen am 14.07.2025. Verfasst von Jenna B Demeter und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology & Critical Care Medicine, University of New Mexico Health Sciences Center, Albuquerque, NM, USA. Hauptthemen laut MEDLINE: Ganglia, Spinal, Gabapentin, Transcriptome, Electrophysiological Phenomena. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NCI NIH HHS, School of Medicine, University of New Mexico, University of New Mexico.
Abstract (Originalsprache)
Neuropathic pain affects approximately 10% of the adult population and is commonly treated with gabapentin (GBP), a repurposed anticonvulsant drug. Despite its widespread use, GBP’s effectiveness varies significantly among patients, highlighting the need to better understand its functional and molecular impacts on human nociceptors. Here we characterized the electrophysiological and transcriptomic effects of GBP on primary neurons derived from the dorsal root ganglia (DRGs) of ethically consented human donors. Using patch-clamp electrophysiology, we demonstrated that GBP treatment reduced neuronal excitability, with more pronounced effects in multi-firing vs. single-firing neurons. Notably, significant donor-specific variability was observed in electrophysiological responsiveness to GBP treatment in vitro. RNA sequencing of DRG tissue from the donor that was more responsive to GBP revealed differences in transcriptome-wide expression of genes associated with ion transport, synaptic transmission, inflammation, and immune response. Cross-transcriptomic analyses further showed that GBP treatment counteracted these alterations, rescuing aberrant gene expression at the pathway level and for several key genes. This study provides a comprehensive electrophysiological and transcriptomic profile of the effects of GBP on human DRG neurons. These findings enhance our understanding of GBP’s mechanistic actions on peripheral sensory neurons and could help optimize its use for managing neuropathic pain.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anesthesiology & Critical Care Medicine, University of New Mexico Health Sciences Center, Albuquerque, NM, USA.
- Division of Urology, Department of Surgery, University of New Mexico Health Sciences Center, Albuquerque, NM, USA.
ORCID-Profile: Jenna B Demeter, Nesia A Zurek, Maddy R Koch, Aleyah E Goins, Mark W Shilling, Sascha Ra Alles, June Bryan I de la Peña
Förderung
- NCI NIH HHS
- School of Medicine, University of New Mexico
- University of New Mexico
Zitieren
APA
Demeter, J. B., Zurek, N. A., Koch, M. R., Goins, A. E., Holguin, C. O., Shilling, M. W., Davis, M. S., Ehsanian, R., Alles, S. R., & de la Peña, J. B. I. (2025). Gabapentin’s effect on human dorsal root ganglia: Donor-specific electrophysiological and transcriptomic profiles. Molecular Pain, 21. https://doi.org/10.1177/17448069251361712
Vancouver
Demeter JB, Zurek NA, Koch MR, Goins AE, Holguin CO, Shilling MW, et al. Gabapentin’s effect on human dorsal root ganglia: Donor-specific electrophysiological and transcriptomic profiles. Molecular Pain. 2025;21. doi:10.1177/17448069251361712
BibTeX
@article{Demeter2025,
author = {Demeter, Jenna B and Zurek, Nesia A and Koch, Maddy R and Goins, Aleyah E and Holguin, Cristian O and Shilling, Mark W and Davis, Michael S and Ehsanian, Reza and Alles, Sascha Ra and de la Peña, June Bryan I},
title = {Gabapentin’s effect on human dorsal root ganglia: Donor-specific electrophysiological and transcriptomic profiles},
journal = {Molecular Pain},
year = {2025},
volume = {21},
doi = {10.1177/17448069251361712}
}
EUVIMED